Hepatitis B virus infection and hepatocellular carcinoma among parous taiwanese women: Nationwide cohort study

Journal of the National Cancer Institute

Volumn 101, Issue 14, 2009, Pages 1019-1027

  Fwu, Chyng Wen ^a   Chien, Yin Chu ^b,c   Kirk, Gregory D ^a   Nelson, Kenrad E ^a   You, San Lin ^b,c   Kuo, Hsu Sung ^d   Feinleib, Manning ^a   Chen, Chien Jen ^b,c  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b GENOMICS RESEARCH CENTER   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d CENTER FOR DISEASE CONTROL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN;

ADULT; AGE DISTRIBUTION; ARTICLE; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE REGISTRY; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INCIDENCE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; NATIONAL HEALTH ORGANIZATION; PARITY; PREGNANCY; PRIORITY JOURNAL; REGISTER; REPRODUCTION; RISK FACTOR; SEROLOGY; TAIWAN; VACCINATION;

ACUTE DISEASE; ADULT; AGE FACTORS; AGED; CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; FEMALE; HEPATITIS B; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B, CHRONIC; HUMANS; INCIDENCE; KAPLAN-MEIERS ESTIMATE; LIVER NEOPLASMS; MIDDLE AGED; PARITY; PREGNANCY; RISK ASSESSMENT; RISK FACTORS; TAIWAN;

EID: 67650815283     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djp146     Document Type: Article

References (38)

1. Beasley RP , Hwang LY , Lin CC , Chien CS. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22,707 men in Taiwan. Lancet. 1981 ; 2 ( 8256 ): 1129 -1133.
2. Kirk GD , Lesi OA , Mendy M , et al. 249(ser) TP53 mutation in plasma DNA, hepatitis B viral infection, and risk of hepatocellular carcinoma. Oncogene. 2005 ; 24 ( 38 ): 5858 -5867.
3. Yang HI , Lu SN , Liaw YF , et al. Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med. 2002 ; 347 ( 3 ): 168 -174.
4. Yu MW , Yeh SH , Chen PJ , et al. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men. J Natl Cancer Inst. 2005 ; 97 ( 4 ): 265 -272.
5. Chen CJ , Yang HI , Su J , et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA. 2006 ; 295 ( 1 ): 65 -73.
6. You SL , Yang HI , Chen CJ. Seropositivity of hepatitis B e antigen and hepatocellular carcinoma. Ann Med. 2004 ; 36 ( 3 ): 215 -224.
7. Chu CM , Liaw YF. HBsAg seroclearance in asymptomatic carriers of high endemic areas: appreciably high rates during a long-term follow-up. Hepatology. 2007 ; 45 ( 5 ): 1187 -1192.
8. McMahon BJ , Holck P , Bulkow L , Snowball M. Serologic and clinical outcomes of 1536 Alaska Natives chronically infected with hepatitis B virus. Ann Intern Med. 2001 ; 135 ( 9 ): 759 -768.
9. Kato Y , Nakao K , Hamasaki K , et al. Spontaneous loss of hepatitis B surface antigen in chronic carriers, based on a long-term follow-up study in Goto Islands, Japan. J Gastroenterol. 2000 ; 35 ( 3 ): 201 -205.
10. Arase Y , Ikeda K , Suzuki F , et al. Long-term outcome after hepatitis B surface antigen seroclearance in patients with chronic hepatitis B. Am J Med. 2006 ; 119 ( 1 ): 71.e9 -71.e16.
11. Chen YC , Sheen IS , Chu CM , Liaw YF. Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with or without concurrent infection. Gastroenterology. 2002 ; 123 ( 4 ): 1084 -1089.
12. Yuen MF , Wong DK , Sablon E , et al. HBsAg seroclearance in chronic hepatitis B in the Chinese: virological, histological, and clinical aspects. Hepatology. 2004 ; 39 ( 6 ): 1694 -1701.
13. Huo TI , Wu JC , Lee PC , et al. Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis. Hepatology. 1998 ; 28 ( 1 ): 231 -236.
14. Chen CJ , Yu MW , Liaw YF. Epidemiological characteristics and risk factors of hepatocellular carcinoma. J Gastroenterol Hepatol. 1997 ; 12 ( 9 -10 ): S294 -S308.
15. Kim CM , Koike K , Saito I , Miyamura T , Jay G. HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature. 1991 ; 351 ( 6324 ): 317 -320.
16. De Maria N , Manno M , Villa E. Sex hormones and liver cancer. Mol Cell Endocrinol. 2002 ; 193 ( 1 -2 ): 59 -63.
17. Wands J. Hepatocellular carcinoma and sex. N Engl J Med. 2007 ; 357 ( 19 ): 1974 -1976.
18. Naugler WE , Sakurai T , Kim S , et al. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science. 2007 ; 317 ( 5834 ): 121 -124.
19. Yu MW , Chang HC , Chang SC , et al. Role of reproductive factors in hepatocellular carcinoma: impact on hepatitis B- and C-related risk. Hepatology. 2003 ; 38 ( 6 ): 1393 -1400.
20. Mucci LA , Kuper HE , Tamimi R , Laqiou P , Spanos E , Trichopoulos D. Age at menarche and age at menopause in relation to hepatocellular carcinoma in women. BJOG. 2001 ; 108 ( 3 ): 291 -294.
21. Lambe M , Trichopoulos D , Hsieh CC , Ekbom A , Pavia M. Parity and hepatocellular carcinoma. A population-based study in Sweden. Int J Cancer. 1993 ; 55 ( 5 ): 745 -747.
22. Stanford JL , Thomas DB. Reproductive factors in the etiology of hepatocellular carcinoma. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Cancer Causes Control. 1992 ; 3 ( 1 ): 37 -42.
23. La Vecchia C , Negri E , Franceschi S , D'Avanzo B. Reproductive factors and the risk of hepatocellular carcinoma in women. Int J Cancer. 1992 ; 52 ( 3 ): 351 -354.
24. Tzonou A , Zavitsanos X , Hsieh CC , Trichopoulos D. Liveborn children and risk of hepatocellular carcinoma. Cancer Causes Control. 1992 ; 3 ( 2 ): 171 -174.
25. Chien YC , Jan CF , Kuo HS , Chen CJ. Nationwide hepatitis B vaccination program in Taiwan: effectiveness in the 20 years after it was launched. Epidemiol Rev. 2006 ; 28 : 126 -135.
26. Chen DS , Hsu NH , Sung JL , et al. A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigencarrier mothers. JAMA. 1987 ; 257 ( 19 ): 2597 -2603.
27. Huang K , Lin S. Nationwide vaccination: a success story in Taiwan. Vaccine. 2000 ; 18 ( suppl 1 ): S35 -S38.
28. Taiwan Cancer Registry. Taiwan Cancer Registry Annual Report. http:// crs.cph.ntu.edu.tw/. Accessed April 19, 2009.
29. Lu TH , Lee MC , Chou MC. Accuracy of cause-of-death coding in Taiwan: types of miscoding and effects on mortality statistics. Int J Epidemiol. 2000 ; 29 ( 2 ): 336 -343.
30. Chen DS , Sung JL. Hepatitis B virus infection and chronic liver diseases in Taiwan. Acta Hepatogastroenterol. 1978 ; 25 ( 6 ): 423 -430.
31. Chen DS. From hepatitis to hepatoma: lessons from type B viral hepatitis. Science. 1993 ; 262 ( 5132 ): 369 -370.
32. Tsai JF , Chuang LY , Jeng JE , et al. Sex differences in relation to serum hepatitis B e antigen and alanine aminotransferase levels among asymptomatic hepatitis B surface antigen carriers. J Gastroenterol. 2000 ; 35 ( 9 ): 690 -695.
33. Liaw YF , Chu CM. Hepatitis B virus infection. Lancet. 2009 ; 373 ( 9663 ): 582 -592.
34. Yuen MF , Wong DK , Fung J , et al. HBsAg seroclearance in chronic hepatitis B in Asian patients: replicative level and risk of hepatocellular carcinoma. Gastroenterology. 2008 ; 135 ( 4 ): 1192 -1199.
35. The population bulletin. Republic of China: Department of Statistics, Ministry of the Interior, Executive Yuan. http://www.ris.gov.tw/ch4/ static/st20-13.xls. Accessed April 19, 2009.
36. Chie WC , Li CY , Huang CS , Chang KJ , Yen ML , Lin RS. Oral contraceptives and breast cancer risk in Taiwan, a country of low incidence of breast cancer and low use of oral contraceptives. Int J Cancer. 1998 ; 77 ( 2 ): 219 -223.
37. Population and Health Research Center. National Survey on Knowledge, Attitude and Practice of Health Promotion, 2002. Taichung, Republic of China : Department of Health, Executive Yuan ; 2003.
38. Wen CP , Cheng TY , Lin CL , et al. The health benefi ts of smoking cessation for adult smokers and for pregnant women in Taiwan. Tob Control. 2005 ; 14 ( suppl 1 ): i56 -i61.